OCC 2.35% 41.5¢ orthocell limited

This deal has been on the table since 2021 after the two year...

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
  1. 1,383 Posts.
    lightbulb Created with Sketch. 227
    This deal has been on the table since 2021 after the two year study that took four years to complete. I had a chat to management at the last AGM, they said they were in talks with a few potential candidates, including J&J.
    One year has passed and nothing, not one word of a potential partnership, what management have decided to do is a few more studies
    ATI vs Rotor cuff
    ATI vs Tennis Elbow
    Now I’m not saying would the likes of J&J Would want results from different tendons / ligaments hence the new study on Rotor cuff Tennis elbow, or are management running out of potential dance partners and are looking at new ways to partner up phase 3 trials, god bless em
 
watchlist Created with Sketch. Add OCC (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.